New insights into the interplay between prions and TDP-43 in neurodegenerative pathology

Neurodegenerative diseases are characterized by the deposition of clumped proteins in the brain and progressive neuronal cell death.

Revolutionary AI tool detects multiple cancers in whole-body PET/CT scans

A novel AI approach can accurately detect six different types of cancer on whole-body PET/CT scans, according to research presented at the 2024 Society of

June 11, 2024

Nonsteroidal MRA Improves Outcomes in HFpEF, HFmrEF

LONDON — The nonsteroidal mineralocorticoid receptor antagonist (MRA) finerenone (Kerendia) improved outcomes driven by soft endpoints in patients with heart failure and mildly reduced or

September 2, 2024

FDA Approves First Drug for WHIM Syndrome

The FDA approved mavorixafor (Xolremdi) capsules as the first therapy specifically for WHIM syndrome, a rare primary immunodeficiency and chronic neutropenic disorder, X4 Pharmaceuticals announced

April 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.